These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18983853)

  • 1. Vancomycin forms ligand-mediated supramolecular complexes.
    Loll PJ; Derhovanessian A; Shapovalov MV; Kaplan J; Yang L; Axelsen PH
    J Mol Biol; 2009 Jan; 385(1):200-11. PubMed ID: 18983853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structures of the complexes between vancomycin and cell-wall precursor analogs.
    Nitanai Y; Kikuchi T; Kakoi K; Hanamaki S; Fujisawa I; Aoki K
    J Mol Biol; 2009 Feb; 385(5):1422-32. PubMed ID: 18976660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A ligand-mediated dimerization mode for vancomycin.
    Loll PJ; Miller R; Weeks CM; Axelsen PH
    Chem Biol; 1998 May; 5(5):293-8. PubMed ID: 9578636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin: ligand recognition, dimerization and super-complex formation.
    Jia Z; O'Mara ML; Zuegg J; Cooper MA; Mark AE
    FEBS J; 2013 Mar; 280(5):1294-307. PubMed ID: 23298227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of vancomycin.
    Schäfer M; Schneider TR; Sheldrick GM
    Structure; 1996 Dec; 4(12):1509-15. PubMed ID: 8994975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structures of glycopeptide antibiotics with peptides that model bacterial cell-wall precursors.
    Lehmann C; Bunkóczi G; Vértesy L; Sheldrick GM
    J Mol Biol; 2002 May; 318(3):723-32. PubMed ID: 12054818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of balhimycin and its complex with solvent molecules.
    Schäfer M; Sheldrick GM; Schneider TR; Vértesy L
    Acta Crystallogr D Biol Crystallogr; 1998 Mar; 54(Pt 2):175-83. PubMed ID: 9761883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of sugar residues in molecular recognition by vancomycin.
    Kaplan J; Korty BD; Axelsen PH; Loll PJ
    J Med Chem; 2001 May; 44(11):1837-40. PubMed ID: 11356118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin binding to low-affinity ligands: delineating a minimum set of interactions necessary for high-affinity binding.
    Loll PJ; Kaplan J; Selinsky BS; Axelsen PH
    J Med Chem; 1999 Nov; 42(22):4714-9. PubMed ID: 10579833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simulated dipeptide recognition by vancomycin.
    Li D; Sreenivasan U; Juranic N; Macura S; Puga FJ; Frohnert PM; Axelsen PH
    J Mol Recognit; 1997; 10(2):73-87. PubMed ID: 9376130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperative binding interactions of glycopeptide antibiotics.
    Shiozawa H; Chia BC; Davies NL; Zerella R; Williams DH
    J Am Chem Soc; 2002 Apr; 124(15):3914-9. PubMed ID: 11942828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The structural biology of molecular recognition by vancomycin.
    Loll PJ; Axelsen PH
    Annu Rev Biophys Biomol Struct; 2000; 29():265-89. PubMed ID: 10940250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformation of A82846B, a glycopeptide antibiotic, complexed with its cell wall fragment: an asymmetric homodimer determined using NMR spectroscopy.
    Prowse WG; Kline AD; Skelton MA; Loncharich RJ
    Biochemistry; 1995 Jul; 34(29):9632-44. PubMed ID: 7626632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dimerization of A82846B, vancomycin and ristocetin: influence on antibiotic complexation with cell wall model peptides.
    Linsdell H; Toiron C; Bruix M; Rivas G; Menéndez M
    J Antibiot (Tokyo); 1996 Feb; 49(2):181-93. PubMed ID: 8621360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction energies between glycopeptide antibiotics and substrates in complexes determined by X-ray crystallography: application of a theoretical databank of aspherical atoms and a symmetry-adapted perturbation theory-based set of interatomic potentials.
    Li X; Volkov AV; Szalewicz K; Coppens P
    Acta Crystallogr D Biol Crystallogr; 2006 Jun; 62(Pt 6):639-47. PubMed ID: 16699191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and self-assembly of NCN-pincer Pd-complex-bound norvalines.
    Ogata K; Sasano D; Yokoi T; Isozaki K; Yoshida R; Takenaka T; Seike H; Ogawa T; Kurata H; Yasuda N; Takaya H; Nakamura M
    Chemistry; 2013 Sep; 19(37):12356-75. PubMed ID: 23907820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface Ligand Density of Antibiotic-Nanoparticle Conjugates Enhances Target Avidity and Membrane Permeabilization of Vancomycin-Resistant Bacteria.
    Hassan MM; Ranzoni A; Phetsang W; Blaskovich MA; Cooper MA
    Bioconjug Chem; 2017 Feb; 28(2):353-361. PubMed ID: 27959504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental and theoretical studies of the structures and interactions of vancomycin antibiotics with cell wall analogues.
    Yang Z; Vorpagel ER; Laskin J
    J Am Chem Soc; 2008 Oct; 130(39):13013-22. PubMed ID: 18774809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syntheses and characterization of copper(II) carboxylate dimers formed from enantiopure ligands containing a strong π···π stacking synthon: enantioselective single-crystal to single-crystal gas/solid-mediated transformations.
    Reger DL; Horger JJ; Debreczeni A; Smith MD
    Inorg Chem; 2011 Oct; 50(20):10225-40. PubMed ID: 21919476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of ristocetin A in complex with a bacterial cell-wall mimetic.
    Nahoum V; Spector S; Loll PJ
    Acta Crystallogr D Biol Crystallogr; 2009 Aug; 65(Pt 8):832-8. PubMed ID: 19622867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.